1684 related articles for article (PubMed ID: 8238183)
21. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
[TBL] [Abstract][Full Text] [Related]
22. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
Fruzzetti F; Ricci C; Fioretti P
Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
[TBL] [Abstract][Full Text] [Related]
23. Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; De Luca P; Egitto M; Granese D; Pullè C; Trimarchi F
Clin Exp Obstet Gynecol; 1991; 18(1):9-12. PubMed ID: 1829030
[TBL] [Abstract][Full Text] [Related]
24. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
25. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
Arangino S; Cagnacci A; Angiolucci M; Longu G; Melis GB; Volpe A
Contraception; 1998 Nov; 58(5):289-93. PubMed ID: 9883384
[TBL] [Abstract][Full Text] [Related]
26. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Petersen KR; Sidelmann J; Skouby SO; Jespersen J
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
Farmer RD; Lawrenson RA
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
[TBL] [Abstract][Full Text] [Related]
28. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
[TBL] [Abstract][Full Text] [Related]
29. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
30. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
Spellacy WN; Tsibris AM; Tsibris JC; George S; Chez RA; O'Brien WF
Contraception; 1994 Feb; 49(2):125-30. PubMed ID: 8143452
[TBL] [Abstract][Full Text] [Related]
32. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
33. Six-month carbohydrate metabolism studies in women using oral contraceptives containing gestodene and ethinyl estradiol.
Spellacy WN; Tsibris JC; Hunter-Bonner DL; Smalling S; Chez RA; Angel JL; O'Brien WF
Contraception; 1992 Jun; 45(6):533-9. PubMed ID: 1617962
[TBL] [Abstract][Full Text] [Related]
34. The effects on hemostasis of oral contraceptives containing desogestrel.
Stubblefield PG
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 2):1047-52. PubMed ID: 8447359
[TBL] [Abstract][Full Text] [Related]
35. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
van Heusden AM; Fauser BC
Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
[TBL] [Abstract][Full Text] [Related]
36. Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease.
Di Lieto A; De Rosa G; Albano G; Pagnano AM; Campanile M; Terracciano L; Pontillo M; Cimmino E; Covelli A; Paladini A
Eur J Obstet Gynecol Reprod Biol; 1994 May; 55(1):71-83. PubMed ID: 7958144
[TBL] [Abstract][Full Text] [Related]
37. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
Endrikat J; Müller U; Düsterberg B
Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
[TBL] [Abstract][Full Text] [Related]
38. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
39. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
40. Contraception in older woman.
Volpe A; Silferi M; Genazzani AD; Genazzani AR
Contraception; 1993 Mar; 47(3):229-39. PubMed ID: 8462314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
